Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Amplia Therapeutics Ltd. (INNMF : OTC)

• Company Description    - Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $0.11 Daily Weekly Monthly 20 Day Moving Average: 3,438 shares Shares Outstanding: 513.31 (millions) Market Capitalization: $56.46 (millions) Beta: 52 Week High: $0.27 52 Week Low: $0.05 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 22.63% 21.73% 12 Week % % Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 90 William Street Level 5 - Melbourne,C3 3000 AUS ph: 130-055-6161 fax: - None http://www.ampliatx.com

• General Corporate Information    Officers Christopher Burns - Chief Executive Officer Warwick Tong - Chairman Robert Peach - Director Jane Bell - Director Andrew j. Cooke - Secretary Peer Information Amplia Therapeutics Ltd. (GSAC) Amplia Therapeutics Ltd. (CASIF) Amplia Therapeutics Ltd. (ALCD.) Amplia Therapeutics Ltd. (OMNN) Amplia Therapeutics Ltd. (CGPI.) Amplia Therapeutics Ltd. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: Q0343V109 SIC: 6770 Fiscal Year Fiscal Year End: March Last Reported Quarter: - Next Expected EPS Date: 09/04/26 Share - Related Items Shares Outstanding: 513.31 Most Recent Split Date: (:1) Beta: Market Capitalization: $56.46 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/04/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - - ROA 06/30/26 - - 03/31/26 - - 12/31/25 - - Current Ratio 06/30/26 - - 03/31/26 - 19.78 12/31/25 - - Quick Ratio 06/30/26 - - 03/31/26 - 19.78 12/31/25 - - Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - -140.39 12/31/25 - - Book Value 06/30/26 - - 03/31/26 - - 12/31/25 - - Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - 0.01 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - 0.63 12/31/25 - -

Powered by Zacks Investment Research ©